Silence Therapeutics Plc ADR (NASDAQ:SLN)’s traded shares stood at 0.72 million during the last session, with the company’s beta value hitting 1.05. At the close
Silence Therapeutics Plc ADR (NASDAQ:SLN)’s traded shares stood at 0.52 million during the last session, with the company’s beta value hitting 1.04. At the close
In last trading session, Silence Therapeutics Plc ADR (NASDAQ:SLN) saw 0.58 million shares changing hands with its beta currently measuring 1.07. Company’s recent per share
Silence Therapeutics Plc ADR (NASDAQ:SLN) has a beta value of 1.12 and has seen 1.49 million shares traded in the last trading session. The company,
During the last session, Silence Therapeutics Plc ADR (NASDAQ:SLN)’s traded shares were 2.33 million, with the beta value of the company hitting 1.14. At the
In the last trading session, 4.5 million shares of the Silence Therapeutics Plc ADR (NASDAQ:SLN) were traded, and its beta was 1.21. Most recently the
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
